Maxime P. Look

13.5k citations

115 papers · 10.0k indexed · 2 hit papers · h-index 49

Impact in

Cancer Research top 0.1%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Protease and Inhibitor Mechanisms
- Cancer-related molecular mechanisms research
Oncology top 0.5%
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis

Papers in

Cancer Research 54
- Protease and Inhibitor Mechanisms 19
- Cancer Genomics and Diagnostics 15
- Breast Cancer Treatment Studies 14
Immunology and Allergy 14
- Cell Adhesion Molecules Research 14

Co-authors: John A. Foekens Anieta M. Sieuwerts Marion E. Meijer‐van Gelder Jan G.M. Klijn Mieke Timmermans Jack X. Yu Dmitri Talantov Fei Yang
Journals: Breast Cancer Research and Treatment (12 papers)British Journal of Cancer (10 papers)Journal of Clinical Oncology (8 papers)International Journal of Cancer (5 papers)Clinical Cancer Research (4 papers)
Partner nations: Netherlands United States Germany

In The Last Decade

Maxime P. Look

114 papers receiving 9.8k citations

Hit Papers

align trajectories log scale

Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer 2005 · 2.1k citations

Peers

Countries citing papers authored by Maxime P. Look

Since Specialization

Citations

This map shows the geographic impact of Maxime P. Look's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maxime P. Look with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maxime P. Look more than expected).

Fields of papers citing papers by Maxime P. Look

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maxime P. Look. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maxime P. Look. The network helps show where Maxime P. Look may publish in the future.

Co-authors

The 25 scholars most cited alongside Maxime P. Look, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Maxime P. Look Line = papers co-authored together Maxime P. Look links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Prospects of Targeting the Gastrin Releasing Peptide Receptor and Somatostatin Receptor 2 for Nuclear Imaging and Therapy in Metastatic Breast Cancer PLoS ONE ·Simone U. Dalm, Willemijne A.M.E. Schrijver, Anieta M. Sieuwerts, Maxime P. Look, Angelique C. J. Ziel – van der Made, Vanja de Weerd, John W.M. Martens, P. J. van Diest, Marion de Jong, Carolien H. M. van Deurzen	2017	10
2	Multivariate meta-analysis of individual participant data helped externally validate the performance and implementation of a prediction model Journal of Clinical Epidemiology ·Kym I E Snell, Harry Hua, Thomas P. A. Debray, Joie Ensor, Maxime P. Look, Karel G.M. Moons, Richard D Riley	2015	45
3	High protein expression of EZH2 is related to unfavorable outcome to tamoxifen in metastatic breast cancer Annals of Oncology ·Esther A. Reijm, A. Mieke Timmermans, Maxime P. Look, Marion E. Meijer‐van Gelder, Claudia Stobbe, Carolien H. M. van Deurzen, John W.M. Martens, Stefan Sleijfer, John A. Foekens, P.M.J.J. Berns, Maurice P.H.M. Jansen	2014	46
4	Long-term results of a randomised phase III trial of weekly versus three-weekly paclitaxel/platinum induction therapy followed by standard or extended three-weekly paclitaxel/platinum in European patients with advanced epithelial ovarian cancer European Journal of Cancer ·M.E.L. van der Burg, Wendy Onstenk, Ingrid Boere, Maxime P. Look, Petronella B. Ottevanger, D. de Gooyer, L.G.M. Kerkhofs, F.A.A. Valster, Jan B. Ruit, A.G.P.M. van Reisen, S.H. Goey, Adelheid M E van der Torren, Daan ten Bokkel Huinink, T.C. Kok, Jaap Verweij, Helena C. van Doorn	2014	28
5	Growth and metastatic behavior of molecularly well-characterized human breast cancer cell lines in mice Breast Cancer Research and Treatment ·Muhammad Riaz, Buddy Setyono-Han, Mieke Timmermans, Anita M.A.C. Trapman, Joan Bolt‐de Vries, Antoinette Hollestelle, Roel C. Janssens, Maxime P. Look, Mieke Schutte, John A. Foekens, John W.M. Martens	2014	6
6	Gene expression profiles in circulating tumor cells to predict prognosis in metastatic breast cancer patients Annals of Oncology ·Bianca Mostert, Anieta M. Sieuwerts, Jaco Kraan, Joan Bolt‐de Vries, Petra van der Spoel, Anne van Galen, Dieter Peeters, Luc Dirix, Caroline Seynaeve, Agnes Jager, Felix E. de Jongh, Paul Hamberg, Jacqueline M. Stouthard, Diederik F.S. Kehrer, Maxime P. Look, Marcel Smid, J.W. Gratama, John A. Foekens, John W.M. Martens, Stefan Sleijfer	2014	45
7	Hotspot mutations in PIK3CA associate with first-line treatment outcome for aromatase inhibitors but not for tamoxifen Breast Cancer Research and Treatment ·Diana Ramirez-Ardila, Jean Helmijr, Maxime P. Look, Irene Lurkin, Kirsten Ruigrok-Ritstier, Steven Van Laere, Luc Dirix, Fred C.G.J. Sweep, Paul N. Span, Sabine C. Linn, John A. Foekens, Stefan Sleijfer, Els M.J.J. Berns, Maurice P.H.M. Jansen	2013	43
8	Correlation of breast cancer susceptibility loci with patient characteristics, metastasis-free survival, and mRNA expression of the nearest genes Breast Cancer Research and Treatment ·Muhammad Riaz, Els M.J.J. Berns, Anieta M. Sieuwerts, Kirsten Ruigrok-Ritstier, Vanja de Weerd, Arwin Groenewoud, André G. Uitterlinden, Maxime P. Look, Jan G.M. Klijn, Stefan Sleijfer, John A. Foekens, John W.M. Martens	2011	46
9	MicroRNA-30c expression level is an independent predictor of clinical benefit of endocrine therapy in advanced estrogen receptor positive breast cancer Breast Cancer Research and Treatment ·F. Germán Rodríguez-González, Anieta M. Sieuwerts, Marcel Smid, Maxime P. Look, Marion E. Meijer‐van Gelder, Vanja de Weerd, Stefan Sleijfer, John W.M. Martens, John A. Foekens	2010	116
10	Prevalence of the variant allele rs61764370 T>G in the 3′UTR of KRAS among Dutch BRCA1, BRCA2 and non-BRCA1/BRCA2 breast cancer families Breast Cancer Research and Treatment ·Antoinette Hollestelle, Cory Pelletier, Maartje J. Hooning, Ellen Crepin, Mieke Schutte, Maxime P. Look, J. Margriet Collée, Anja Nieuwlaat, Lambert C. J. Dorssers, Caroline Seynaeve, Yurii S. Aulchenko, John W.M. Martens, Ans M.W. van den Ouweland, Joanne B. Weidhaas	2010	28
11	Distinct inherited metastasis susceptibility exists for different breast cancer subtypes: a prognosis study Breast Cancer Research ·Szu‐Min Hsieh, Maxime P. Look, Anieta M. Sieuwerts, John A. Foekens, Kent W. Hunter	2009	43
12	Association of an Extracellular Matrix Gene Cluster with Breast Cancer Prognosis and Endocrine Therapy Response Clinical Cancer Research ·Jozien Helleman, Maurice P.H.M. Jansen, Kirsten Ruigrok-Ritstier, Iris L. van Staveren, Maxime P. Look, Marion E. Meijer‐van Gelder, Anieta M. Sieuwerts, Jan G.M. Klijn, Stefan Sleijfer, John A. Foekens, Els M.J.J. Berns	2008	142
13	Association of DNA Methylation of Phosphoserine Aminotransferase with Response to Endocrine Therapy in Patients with Recurrent Breast Cancer Cancer Research ·John W.M. Martens, Inko Nimmrich, Thomas Koenig, Maxime P. Look, Nadia Harbeck, Fabian Model, Antje Kluth, Joan Bolt‐de Vries, Anieta M. Sieuwerts, Henk Portengen, Marion E. Meijer‐van Gelder, Christian Piepenbrock, Alexander Olek, Heinz Höfler, Marion Kiechle, Jan G.M. Klijn, Manfred Schmitt, Sabine Maier, John A. Foekens	2005	102
14	Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer The Lancet ·Yixin Wang, Jan G.M. Klijn, Yi Zhang, Anieta M. Sieuwerts, Maxime P. Look, Fei Yang, Dmitri Talantov, Mieke Timmermans, Marion E. Meijer‐van Gelder, Jack X. Yu, Tim Jatkoe, Els M.J.J. Berns, David Atkins, John A. Foekens Hit paper breakdown →	2005	2097
15	Prognostic impact of urokinase-type plasminogen activator receptor (uPAR) in cytosols and pellet extracts derived from primary breast tumours British Journal of Cancer ·J Witte, John A. Foekens, Nils Brünner, J.J.T.M. Heuvel, ThH van Tienoven, Maxime P. Look, Jan G. M. Klijn, Anneke Geurts‐Moespot, Nicolaï Grebenchtchikov, T J Benraad, Fred C.G.J. Sweep	2001	38
16	Clinical relevance of biologic factors in male breast cancer Breast Cancer Research and Treatment ·Marion E. Meijer‐van Gelder, Maxime P. Look, Joan Bolt‐de Vries, Harry A. Peters, Jan G.M. Klijn, John A. Foekens	2001	43
17	The prognostic significance of expression of the multidrug resistance-associated protein (MRP) in primary breast cancer British Journal of Cancer ·Kees Nooter, Guy Brutel de la Rivière, Maxime P. Look, Kyra E. van Wingerden, S.C. Henzen‐Logmans, Rik J. Scheper, M J Flens, J.G.M. Klijn, G. Stoter, John A. Foekens	1997	116
18	The prognostic value of epidermal growth factor receptor (EGF-R) in primary breast cancer: Results of a 10 year follow-up study Breast Cancer Research and Treatment ·Jan G.M. Klijn, Maxime P. Look, Henk Portengen, J. Alexieva-Figusch, Wim L.J. van Putten, John A. Foekens	1994	101
19	Systemic neurohumoral activation and vasoconstriction during pacing-induced acute myocardial ischemia in patients with stable angina pectoris The American Journal of Cardiology ·Willem J. Remme, Peter W. de Leeuw, Marianne Bootsma, Maxime P. Look, Dick A.C.M. Kruijssen	1991	17
20	Hemodynamic Effects of Intravenous Pimobendan in Patients with Left Ventricular Dysfunction Journal of Cardiovascular Pharmacology ·Willem J. Remme, Ans C.P. Wiesfeld, Maxime P. Look, H. A. C. M. Kruyssen	1989	17

About Maxime P. Look

Maxime P. Look is a scholar working on Cancer Research, Immunology and Allergy, Oncology, Genetics and Molecular Biology, having authored 115 papers that have together received 10.0k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (19 papers), Estrogen and related hormone effects (17 papers), HER2/EGFR in Cancer Research (15 papers), Cancer Genomics and Diagnostics (15 papers), Cell Adhesion Molecules Research (14 papers), Breast Cancer Treatment Studies (14 papers), Epigenetics and DNA Methylation (10 papers) and Cancer-related Molecular Pathways (10 papers). The work is most often cited by research in Cancer Research (4.5k citations), Oncology (3.6k citations), Immunology and Allergy (649 citations), Molecular Biology (5.9k citations) and Genetics (1.2k citations). Maxime P. Look has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include John A. Foekens, Anieta M. Sieuwerts, Marion E. Meijer‐van Gelder, Jan G.M. Klijn, Mieke Timmermans, Jack X. Yu, Dmitri Talantov, Fei Yang, Els M.J.J. Berns and J.G.M. Klijn. Their work appears in journals such as Breast Cancer Research and Treatment, British Journal of Cancer, Journal of Clinical Oncology, International Journal of Cancer and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact